PRAX — Praxis Precision Medicines, Inc. catalysts

Name: Bio Catalyst Calendar — source-anchored biotech/pharma catalyst dates
Creator: Bio Catalyst Calendar
License: https://www.usa.gov/government-works

3 verified catalyst event(s) for Praxis Precision Medicines, Inc. (ticker PRAX). Each is linked to its official source. Verified as of 2026-09-20.

Next verified catalyst

2026-12-01 — A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and P · official source ↗

Upcoming

Date	Event	Company	Drug	Official source & verification
2026-12 (month) in 2mo ESTIMATED	READOUT A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerabil Phase 3 · Developmental and Epileptic Encephalopathy 1	PRAX Praxis Precision Medicines,	1.0mg/kg/day PRAX-562, 1.5mg/kg/day PRAX	ClinicalTrials.gov ↗ ✓ Source-checked 2026-09-20 Sponsor-projected date — can change
2026-12 (month) in 2mo ESTIMATED	READOUT A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Saf Phase 3 · Epileptic Encephalopathy, SCN2A Encephalopathy	PRAX Praxis Precision Medicines,	1mg elsunersen, 0.5mg elsunersen	ClinicalTrials.gov ↗ ✓ Source-checked 2026-09-20 Sponsor-projected date — can change
2027-01 (month) in 3mo ESTIMATED	READOUT Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Phase 3 · Focal Epilepsy	PRAX Praxis Precision Medicines,	40 mg/day vormatrogine for 12 weeks, 30	ClinicalTrials.gov ↗ ✓ Source-checked 2026-09-20 Sponsor-projected date — can change